@article{3109919,
    title = "Epidemiology of community-acquired pneumonia hospitalizations and associated complications before and after the implementation of the heptavalent pneumococcal conjugate vaccine in Athens, Greece",
    author = "Lagousi, T. and Papadatou, I. and Kopsidas, I. and Critselis, E. and Theodoridou, M. and Spoulou, V.",
    journal = "Journal of the Pediatric Infectious Diseases Society",
    year = "2015",
    volume = "4",
    number = "3",
    pages = "260-263",
    publisher = "Oxford University Press",
    issn = "2048-7193, 2048-7207",
    doi = "10.1093/jpids/pit088",
    keywords = "Pneumococcus vaccine;  Pneumococcus vaccine, acute respiratory failure;  adolescent;  Article;  bacterial virulence;  child;  community acquired pneumonia;  empyema;  Greece;  hemolytic uremic syndrome;  hospital admission;  hospitalization;  human;  infant;  lung abscess;  pleura effusion;  priority journal;  retrospective study;  septic shock;  septicemia;  systemic inflammatory response syndrome;  vaccination;  Community-Acquired Infections;  diagnostic test;  immunology;  newborn;  Pneumococcal Infections;  pneumonia;  preschool child;  tertiary care center;  vaccine immunogenicity, Child;  Child, Preschool;  Community-Acquired Infections;  Diagnostic Tests, Routine;  Greece;  Heptavalent Pneumococcal Conjugate Vaccine;  Humans;  Immunogenicity, Vaccine;  Infant;  Infant, Newborn;  Pneumococcal Infections;  Pneumonia;  Retrospective Studies;  Tertiary Care Centers",
    abstract = "We determined the rates of community-acquired pneumonia (CAP)-associated hospitalizations and complications in Athens, over a period covering 4 years before and 4 years after the implementation of the 7-valent pneumococcal vaccine (PCV7) in Greece. PCV7 had no impact on pediatric CAP rates, whereas there was an increase in CAP-associated complications. © The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society."
}